Last reviewed · How we verify

NCT03945461

Return of Bowel Function After One or Two Level Anterior Lumbar Interbody Fusion With Chewing Gum

Completed NA Last updated 26 April 2024
What this trial tests

NA trial testing Chewing gum in Spondylosis in 50 participants. Completed in 30 December 2023.

Timeline
13 February 2019
Primary endpoint
30 December 2023
30 December 2023

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment50
Start date13 February 2019
Primary completion30 December 2023
Estimated completion30 December 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

Adults 18 to 85, any sex, with Spondylosis or Spondylolisthesis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Researchers are trying to identify is chewing gum improves bowel function after anterior lumbar interbody fusion

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Chewing gum

Trials testing the same drug.

Other recruiting trials for Spondylosis

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03945461.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing